The third quarter of 2024 presented significant challenges for the financial performance of the Indian division of the German chemical giant BASF $BAS.DE. On Tuesday, BASF India $BASF.NS reported a 26.1% drop in profit to 1.04 billion rupees ($11.95 million), down from 1.4 billion rupees a year earlier. This decline was primarily due to the rise in raw material costs and overall operating expenses, despite sustained product demand.
The essential drivers impacting the third-quarter profit include:
1. Increased Raw Material Costs. The costs associated with raw materials rose by 7.9%, becoming a major expenditure for BASF India. Overall expenses for the company increased by 15%, significantly reducing net profit.
In December 2024, two of Japan's leading automotive giants, Honda Motor Co. $HMC and Nissan Motor Co. $NSANY, announced the initiation of merger discussions aimed at creating a joint holding company. This partnership was projected to take effect in 2026, with each manufacturer operating under its own brand. Initially, these negotiations were seen as an equal merger.
Recently, Honda proposed new terms under which Nissan would become a subsidiary. This proposal elicited a mixed response from Nissan, thereby putting the entire alliance agreement at risk.
Initially, the details of the Honda and Nissan collaboration were set to be revealed at the end of January. However, decision-making processes were delayed, and now both companies plan to present this information by mid-February.
State Bank of India $SBIN.NS, the largest lender in the country, plans to raise approximately 50 billion rupees ($573.38 million) through the issuance of additional perpetual bonds of the Tier 1 category, meeting Basel III standards. This issuance is expected to be completed by the end of February, according to information from three informed sources.
These sources also disclosed that there is an option for early redemption at the end of the five- or ten-year period after issuance. It is important to note that the sources chose to remain anonymous due to a lack of official authorization to speak to the media.
Japanese company SKY Perfect JSAT $9412.T is poised to significantly enhance its position in the Earth observation satellite market. On Wednesday, the company announced a project worth around $230 million, aimed at creating a constellation of low Earth orbit satellites. This initiative will incorporate Pelican satellites developed by the American company Planet Labs $PL.
The key factors driving JSAT to make this significant investment are outlined below:
Total Specific Solutions (TSS), a Dutch software development company, has made a significant investment decision by finalizing an agreement to acquire an additional 14.84% stake in Polish software company Asseco Poland $ACP.WA. This strategic move establishes TSS as the largest shareholder, presenting new opportunities for both companies.
In late January, TSS acquired 9.99% of Asseco's shares from Cyfrowy Polsat $CPS.WA. With the completion of this new transaction, TSS will hold 24.84% of Asseco's shares through its subsidiary, Yukon Niebieski Capital. The transaction price was set at 85 PLN per share, consistent with the previous purchase from Cyfrowy Polsat.
Santander Bank $SC has revealed plans to return substantial funds to investors through a share buyback program scheduled for 2025 and 2026. The total amount intended for return to shareholders is set at 10 billion euros (approximately 10.39 billion USD). This move is facilitated by the bank's record profit levels and expected surplus capital.
Santander's net profit for the fourth quarter grew by 11% compared to the same period last year. The primary growth drivers included successful retail operations in Spain and Brazil, along with increased income that offset a decline in consumer lending volumes.
Bunge Global SA $BG, a leading global trader in agricultural products, has projected a less favorable outlook for its profit this year. Amid escalating geopolitical uncertainty and volatile global commodity markets, the company anticipates its adjusted earnings for 2025 to drop to the lowest level since the onset of the pandemic.
In its recent report, Bunge indicated that the forecasted adjusted earnings for the full year will be $7.75 per share. This represents a 16% decrease compared to the previous year and falls below consensus estimate. This figure also marks the lowest for the company since 2019. Following these announcements, Bunge's shares dropped by 4.7% in pre-market trading in New York, signaling concerns within the market.
The company attributes the decline in performance to a combination of factors, principally heightened volatility in food supply, restricted export capabilities, and significant geopolitical tension.
Danish company Vestas $VWS.CO, the world's largest manufacturer of wind turbines, has consistently maintained its reputation as a leader in the renewable energy sector. Recently, Vestas reported higher-than-expected adjusted operating profit for the fourth quarter, despite global uncertainties. Let's delve into the key points and future prospects of the company.
According to the report, Vestas' operating profit before special items increased to 759 million euros (788 million dollars) compared to 191 million euros in the same period last year. This impressive growth surpassed the average analyst forecast of 672 million euros. This indicates Vestas' ability to effectively adapt to market challenges and enhance its operational efficiency.
Despite positive financial results, the company warns of ongoing uncertainty in 2025. The continuation of geopolitical and trade instability remains a significant risk factor. However, the expectation of fulfilling a record volume of orders instills confidence in future profit growth.
In January this year, Bridgewater Associates' fla $BWB gship fund, Pure Alpha, demonstrated a significant growth of 8.2%, which stands out against the backdrop of market uncertainty and the sell-off in stocks related to artificial intelligence.
While many investors were concerned about market instability caused by the transition of the new U.S. administration, Ray Dalio's fund performed remarkably. An 8.2% rise in January highlights the resilience and flexibility of Pure Alpha's strategies in challenging market conditions.
Last year was also successful for the Pure Alpha fund. With a return rate of 11.3%, the fund continues to be a reliable instrument for investors focused on macroeconomic volatility. This strategy allows taking global economic trends into account and quickly adapting to changes.
The American biotechnology company Amgen $AMGN has released its quarterly profit report, noting an impressive 11% increase in sales. In addition to this financial upturn, Amgen outlined ambitious plans for a key drug candidate aimed at combating obesity. However, the company faced regulatory setbacks as trials for another weight-loss drug were temporarily suspended, leading to some uncertainties in the market.
Amgen has showcased a substantial improvement in its financial results compared to previous periods. The company's product sales increased by 11% this quarter, significantly boosting its profits. Despite this positive trend, shares experienced a slight decline, falling about 1% to $285.50 in after-hours trading, even though the stock price has surged by over 11% since the beginning of the year.
EssilorLuxottica $EL.PA, a leading company in the optics and eyewear industry, has announced a significant milestone in the advancement of its technologies. On Monday, the company confirmed receiving clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking over-the-counter Nuance $NUAN audio glasses.
Nuance is a unique device that combines the capabilities of hearing aids with the aesthetics and functionality of prescription eyewear. This product is set to be available in the United States and Italy in the first quarter of 2025. EssilorLuxottica also plans to launch the glasses in several European countries, including France, Germany, and the United Kingdom, in the first half of 2025.
Kyndryl $KD, formerly an IBM $IBM division, has reported third-quarter earnings that fell short of Wall Street expectations. Despite strong demand for artificial intelligence, the company's revenues were negatively impacted by the strengthening dollar and a strategic shift away from low-margin deals.
Kyndryl noted that over 74% of its third-quarter revenue came from international markets. This currency imbalance posed several challenges: